The inability to take medications openly at home: does it help explain gender disparities in HAART use?

Journal of Women's Health
Jennifer N SaylesWilliam E Cunningham

Abstract

Previous studies have shown that HIV-positive women underuse highly active antiretroviral therapy (HAART), but the reasons for this gender disparity are not completely understood. We examined whether one reason for this disparity is that women are less likely to use HAART when they have difficulty taking HIV medications openly at home. This was a prospective cohort study of a national probability sample of 2864 adults receiving HIV care. Among the 1910 people who participated in the follow-up survey and reported taking HIV medications, 11.8% reported they could not take HIV medications openly at home. Those who reported they had difficulty taking medications openly at home were more likely to be women, to be black, to live in the northeast United States, to have an annual income <5,000 US dollars, and to have no health insurance. In bivariate analysis, women had twice the odds of reporting difficulty taking medications openly (odds ratio [OR] 2.07, 95% confidence interval [CI] 1.36-3.15) compared with gay/bisexual men, although this gender difference was no longer significant in the adjusted model. For women, having difficulty taking medications openly at home was associated with a substantial decrease in the probability of bei...Continue Reading

References

Jul 1, 1992·The Journal of Infectious Diseases·G F LempS R Hernandez
Jan 1, 1991·Journal of General Internal Medicine·M D SteinC C Carpenter
Jan 1, 1993·Women & Health·H V McCoy, J A Inciardi
Aug 1, 1996·American Journal of Public Health·K J SikkemaM B Mercer
Feb 18, 1998·JAMA : the Journal of the American Medical Association·R S HoggJ S Montaner
Dec 24, 1998·The New England Journal of Medicine·S A BozzetteM F Shapiro
Jul 1, 1999·JAMA : the Journal of the American Medical Association·M F ShapiroS A Bozzette
Feb 10, 2000·American Journal of Public Health·S ZierlerS A Bozzette
Jul 18, 2000·American Journal of Public Health·M D SteinM A Schuster
Oct 18, 2000·Journal of Acquired Immune Deficiency Syndromes : JAIDS·A MocroftA N Phillips
Jul 26, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Judith A CookMary Young
Apr 8, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·A D McNaghtenUNKNOWN Adult/Adolescent Spectrum of HIV Disease Group
Dec 20, 2003·The Journal of the Association of Nurses in AIDS Care : JANAC·Linda Manfrin-Ledet, Demetrius J Porche
Jun 30, 2004·AIDS Care·R L KlitzmanUNKNOWN NIMH Healthy Living Trial Group
Jul 1, 2004·American Journal of Public Health·Mardge H CohenTracey E Wilson
Dec 21, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Kelly A GeboUNKNOWN HIV Research Network
May 4, 2005·Journal of Psychosomatic Research·Karolynn Siegel, Eric W Schrimshaw

❮ Previous
Next ❯

Citations

Jun 15, 2010·AIDS·Linda G MarcUNKNOWN National Haitian-American Health Alliance
Aug 6, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Mirjam-Colette KempfMichael S Saag
May 27, 2011·BMC Public Health·Quarraisha Abdool KarimShirin Heidari
Jul 14, 2012·Patient Preference and Adherence·Jennifer M CocohobaRuth M Greenblatt
Feb 5, 2008·Journal of Women's Health·Paula BraitsteinUNKNOWN Antiretroviral Therapy in Lower Income Countries (ART-LINC) study group
Dec 31, 2010·Journal of Women's Health·Vidya MaveDavid Mushatt
Mar 8, 2008·Research in Nursing & Health·Margarete SandelowskiEun-Jeong Lee
May 27, 2015·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Sabina A HaberlenMaria J Wawer
Mar 1, 2012·Journal of the International Association of Physicians in AIDS Care : JIAPAC·Jean B NachegaRenslow Sherer
Feb 1, 2008·Expert Review of Pharmacoeconomics & Outcomes Research·Edward Stenehjem, Judith C Shlay
Apr 23, 2017·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Laura M BogartGlenn J Wagner
Oct 20, 2018·AIDS and Behavior·Erik D StorholmGlenn J Wagner
Nov 5, 2013·Canadian Journal of Public Health = Revue Canadienne De Santé Publique·James WeaverMarsha Brown
Mar 11, 2021·AIDS Patient Care and STDs·Amanda Blair SpenceSeble Kassaye

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.